These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24471579)

  • 1. Effects of the tea catechin epigallocatechin gallate on Porphyromonas gingivalis biofilms.
    Asahi Y; Noiri Y; Miura J; Maezono H; Yamaguchi M; Yamamoto R; Azakami H; Hayashi M; Ebisu S
    J Appl Microbiol; 2014 May; 116(5):1164-71. PubMed ID: 24471579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea catechins potentiate the effect of antibiotics and modulate adherence and gene expression in Porphyromonas gingivalis.
    Fournier-Larente J; Morin MP; Grenier D
    Arch Oral Biol; 2016 May; 65():35-43. PubMed ID: 26849416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of antibiotics and an N-acyl homoserine lactone analog on Porphyromonas gingivalis biofilms.
    Asahi Y; Noiri Y; Igarashi J; Suga H; Azakami H; Ebisu S
    J Appl Microbiol; 2012 Feb; 112(2):404-11. PubMed ID: 22093286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis.
    Maezono H; Noiri Y; Asahi Y; Yamaguchi M; Yamamoto R; Izutani N; Azakami H; Ebisu S
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5887-92. PubMed ID: 21911560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea extract and its major constituent, epigallocatechin-3-gallate, induce epithelial beta-defensin secretion and prevent beta-defensin degradation by Porphyromonas gingivalis.
    Lombardo Bedran TB; Feghali K; Zhao L; Palomari Spolidorio DM; Grenier D
    J Periodontal Res; 2014 Oct; 49(5):615-23. PubMed ID: 24206194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of tea catechin epigallocatechin-3-gallate against biofilms formed from Streptococcus mutans and a probiotic lactobacillus strain.
    Wu CY; Su TY; Wang MY; Yang SF; Mar K; Hung SL
    Arch Oral Biol; 2018 Oct; 94():69-77. PubMed ID: 29979975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea epigallocatechin-3-gallate alleviates Porphyromonas gingivalis-induced periodontitis in mice.
    Cai Y; Chen Z; Liu H; Xuan Y; Wang X; Luan Q
    Int Immunopharmacol; 2015 Dec; 29(2):839-845. PubMed ID: 26359545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response.
    Zhou W; Zhang X; Zhu CL; He ZY; Liang JP; Song ZC
    PLoS One; 2016; 11(11):e0166442. PubMed ID: 27832188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of N-acyl homoserine lactone analogues on Porphyromonas gingivalis biofilm formation.
    Asahi Y; Noiri Y; Igarashi J; Asai H; Suga H; Ebisu S
    J Periodontal Res; 2010 Apr; 45(2):255-61. PubMed ID: 19778324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tea catechin epigallocatechin gallate inhibits Streptococcus mutans biofilm formation by suppressing gtf genes.
    Xu X; Zhou XD; Wu CD
    Arch Oral Biol; 2012 Jun; 57(6):678-83. PubMed ID: 22169220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green tea extract and its major constituent epigallocatechin-3-gallate inhibit growth and halitosis-related properties of Solobacterium moorei.
    Morin MP; Bedran TB; Fournier-Larente J; Haas B; Azelmat J; Grenier D
    BMC Complement Altern Med; 2015 Mar; 15():48. PubMed ID: 25880992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts.
    Yun JH; Pang EK; Kim CS; Yoo YJ; Cho KS; Chai JK; Kim CK; Choi SH
    J Periodontal Res; 2004 Oct; 39(5):300-7. PubMed ID: 15324350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metronidazole on Porphyromonas gingivalis biofilms.
    Wright TL; Ellen RP; Lacroix JM; Sinnadurai S; Mittelman MW
    J Periodontal Res; 1997 Jul; 32(5):473-7. PubMed ID: 9266499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial effects of epigallocatechin-3-gallate, a catechin abundant in green tea, on periodontal disease-associated bacteria.
    Higuchi M; Abiko Y; Washio J; Takahashi N
    Arch Oral Biol; 2024 Nov; 167():106063. PubMed ID: 39128436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea polyphenols enhance gingival keratinocyte integrity and protect against invasion by Porphyromonas gingivalis.
    Lagha AB; Groeger S; Meyle J; Grenier D
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29635433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3-gallate attenuates Porphyromonas gingivalis lipopolysaccharide-enhanced matrix metalloproteinase-1 production through inhibition of interleukin-6 in gingival fibroblasts.
    Wen WC; Kuo PJ; Chiang CY; Chin YT; Fu MM; Fu E
    J Periodontol; 2014 Jun; 85(6):868-75. PubMed ID: 24215203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin gallate inhibits biofilm formation by ocular staphylococcal isolates.
    Blanco AR; Sudano-Roccaro A; Spoto GC; Nostro A; Rusciano D
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4339-43. PubMed ID: 16189116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Resveratrol on biofilm formation and virulence factor gene expression of Porphyromonas gingivalis in periodontal disease.
    Kugaji MS; Kumbar VM; Peram MR; Patil S; Bhat KG; Diwan PV
    APMIS; 2019 Apr; 127(4):187-195. PubMed ID: 30861212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Epigallocatechin gallate against Enterococcus faecalis biofilm and virulence.
    Lee P; Tan KS
    Arch Oral Biol; 2015 Mar; 60(3):393-9. PubMed ID: 25526623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilm.
    Vidigal PG; Müsken M; Becker KA; Häussler S; Wingender J; Steinmann E; Kehrmann J; Gulbins E; Buer J; Rath PM; Steinmann J
    PLoS One; 2014; 9(4):e92876. PubMed ID: 24690894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.